642 results on '"Paner, Gladell P."'
Search Results
2. The influence of the cancer label on perceptions and management decisions for low-grade prostate cancer.
3. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
4. NKX3.1 Expression in Non-Prostatic Tumors and Characterizing its Expression in Esophageal/Gastroesophageal Adenocarcinoma
5. Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance
6. Novel and Emerging Concepts in Genitourinary Tumors Empowered in the Multidisciplinary and Molecular Era
7. Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness.
8. Glandular Lesions of the Urinary Bladder: Diagnostic and Molecular Updates
9. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas
10. Physician Perception of Grade Group 1 Prostate Cancer
11. Application of ChatGPT in Routine Diagnostic Pathology: Promises, Pitfalls, and Potential Future Directions
12. Flat intraurothelial lesions of the urinary bladder—do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice
13. Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer.
14. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
15. Renaming Grade Group 1 Prostate “Cancer” From a Pathology Perspective: A Call for Multidisciplinary Discussion
16. Supplementary Figure 5 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
17. Supplementary Table 19 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
18. Supplementary Figure 3 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
19. Supplementary Figure 2 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
20. Supplementary Table 4 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
21. Supplementary Table 3 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
22. Supplementary Figure 8 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
23. Supplementary Figure 4 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
24. Supplementary Figure 9 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
25. Data from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
26. Supplementary Figure 6 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
27. Supplementary Table 2 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
28. Supplementary Table 7 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
29. Supplementary Figure 1 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
30. Supplementary Table 9 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
31. Supplementary Table 5 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
32. Supplementary Table 8 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
33. Supplementary Table 6 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
34. Supplementary Figure 7 from The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men
35. SOX2 mediates metabolic reprogramming of prostate cancer cells
36. Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists’ measures
37. Should Grade Group 1 (GG1) be called cancer?
38. The impact of inherited genetic variation on DNA methylation in prostate cancer and benign tissues of African American and European American men
39. Surgical pathology of cystic renal cell carcinomas: is there an overestimation of malignancy?
40. Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections
41. Comparaison des classifications TNM des 8es éditions de l’UICC et de l’AJCC en uropathologie
42. Overview and Staging of Renal Neoplasms
43. Polycystic Kidney Disease
44. Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios
45. Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra
46. Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cells
47. Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists
48. Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder
49. College of American Pathologists Cancer Protocols: From Optimizing Cancer Patient Care to Facilitating Interoperable Reporting and Downstream Data Use
50. Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.